Advertisement

The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol

Egrifta Dosages

Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts

is it ok to lower Egrifta dosage frequency?

I was wondering if after being on Egrifta for a year, is it okay to lower dose taken to less than every day? Will I regain the weight if i only take the dose one to two times per week? If not that would be great as it would save money and injection...
Nelson Vergel, B.S.Ch.E., M.B.A.

Response from Nelson Vergel, B.S.Ch.E., M.B.A.

Program for Wellness Restoration
This is an excellent question to which we have no answer. But one that I will bring up to Serono and Theratecnologies for studies.I think eventually most people will get tired of injecting this drug every day, and it is to the best interest of the... Read more »

Nelson, what's going on with Egrifta?

I am on ADAP. Can I get it now? My lipodystrophy belly is pretty big and I need to do something... Read more »

joint pain for egrifta

hi., i been using egrifta for the last 2 months , when i start seeing results , my both hands,... Read more »
Articles
U.S. Food and Drug Administration

FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV

On November 10, 2010, the Food and Drug Administration approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach, and... Read more »
San Francisco AIDS Foundation

Tesamorelin Approved for Lipodystrophy

In November, the FDA approved tesamorelin (Egrifta; formerly known as TH9507) for treatment of a type of lipodystrophy in HIV positive people taking antiretroviral therapy. Tesamorelin is a synthetic growth hormone-releasing factor that stimulates... Read more »
Housing Works

Belly Fat Drug Debated Even Before FDA Approval

Drugs into bodies ... not as clearcut as it sounds. Tesamorelin (expected to be called "Egrifta" if and when it is marketed and sold in the United States by the company EMD Serono) is an experimental drug that seeks to limit or reduce belly fat... Read more »
Project Inform

New Treatment for Excess Deep Belly Fat Approved

In November 2010, a new drug called tesamorelin (Egrifta) was approved by the FDA to treat excess deep belly fat in HIV-positive people. The drug is a synthetic human growth hormone releasing factor that stimulates the pituitary gland to make growth... Read more »
Connect With Others

Egrifta tesamorelin, is it available?

Posted by artnut, 2 Replies
Positively Aware has an article (July/August 2010)on the FDA approving Egrifta for the treatment of belly fat. Is it available? Has anyone had any experience with it? The biggest problem seems injecting oneself. How about blood sugar levels? ... Read more »

Egrifta

Posted by Jameser, 4 Replies
I have been diagnosed with HIV associated lipodystrophy causing a huge belly. I'm 27 years old and I've tried exercise, changing my diet, among other things to try to lose the belly. I recently talked to my doctor about starting Egrifta and he... Read more »

Egrifta /tesamorelin

Posted by ricky1, 1 Reply
I was diagnosed with lypodystrophy my dr referred me to an epidemiologist for help 2 years ago,My insrence company will cover it.but I had to go through a third party that will help pay for the copay. I was in a study with serostim but the... Read more »

Advertisement